Conformation and energy investigation of microtubule longitudinal dynamic instability induced by natural products

Chem Biol Drug Des. 2023 Sep;102(3):444-456. doi: 10.1111/cbdd.14189. Epub 2022 Dec 15.

Abstract

The natural products plinabulin, docetaxel, and vinblastine are microtubule targeting agents (MTAs). They have been used alone or in combination in cancer treatment. However, the exact nature of their effects on microtubule (MT) polymerization dynamics is poorly understood. To elucidate the longitudinal conformational and energetic changes during MT dynamics, a total of 140 ns molecular dynamic simulations combined with binding free energy calculations were performed on seven tubulin models. The results indicated that the drugs disrupted MT polymerization by altering both MT conformation and binding free energy of the neighboring tubulin subunits. The combination of plinabulin and docetaxel destabilized MT polymerization due to bending MT and weakening the polarity of tubulin polymerization. The new combination of docetaxel and vinblastine synergistically enhanced MT depolymerization and bending, while plinabulin and vinblastine had no synergistic inhibitory effects. The results were verified by the tubulin assembly assay. Our study obtained a comprehensive understanding of the action mechanisms of three natural drugs and their combinations on MT dynamic, provided theoretical guidance for new MTA combinations, and would promote the optimal use of MTA and contribute to developing new MTAs as anticancer agents.

Keywords: Plinabulin; docetaxel; microtubule; microtubule targeting agents; vinblastine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Docetaxel / metabolism
  • Docetaxel / pharmacology
  • Microtubules
  • Tubulin Modulators* / chemistry
  • Tubulin Modulators* / pharmacology
  • Tubulin* / metabolism
  • Vinblastine / analysis
  • Vinblastine / metabolism
  • Vinblastine / pharmacology

Substances

  • Antineoplastic Agents
  • Docetaxel
  • Tubulin
  • Vinblastine
  • Tubulin Modulators